Profile of Baricitinib and Its Potential in the Treatment of Moderate to Severe Atopic Dermatitis: A Short Review on the Emerging Clinical Evidence
Maddalena Napolitano,1 Gabriella Fabbrocini,2 Eleonora Cinelli,2 Luca Stingeni,3 Cataldo Patruno4 1Department of Medicine and Health Sciences Vincenzo Tiberio, University of Molise, Campobasso, Italy; 2Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico...
Main Authors: | Napolitano M, Fabbrocini G, Cinelli E, Stingeni L, Patruno C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-01-01
|
Series: | Journal of Asthma and Allergy |
Subjects: | |
Online Access: | https://www.dovepress.com/profile-of-baricitinib-and-its-potential-in-the-treatment-of-moderate--peer-reviewed-article-JAA |
Similar Items
-
Emerging systemic JAK inhibitors in the treatment of atopic dermatitis: a review of abrocitinib, baricitinib, and upadacitinib
by: Novin Nezamololama, et al.
Published: (2020-11-01) -
JAK-STAT Inhibitors in Atopic Dermatitis from Pathogenesis to Clinical Trials Results
by: Krzysztof Szalus, et al.
Published: (2020-11-01) -
The Efficacy and Safety of Abrocitinib as a Treatment Option for Atopic Dermatitis: A Short Report of the Clinical Data
by: Napolitano M, et al.
Published: (2021-03-01) -
Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis
by: Michelle Le, et al.
Published: (2021-09-01) -
Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
by: Ana M. Montilla, et al.
Published: (2019-10-01)